DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Ning Y-M. et al.
FDA Approval Summary: Atezolizumab for the Treatment of Patients with Progressive Advanced Urolethial Carcinoma after Platinum-Containing Chemotherapy.
The Oncologist 2017;
22: 743-748
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.